Category: elsevier

Researcher in Brazil earns 12th retraction for recycling text and figures

Thermochimica ActaA scientist in Brazil has gained his twelfth retraction for reusing text and figures from previously published papers.

In 2011, Elsevier announced that it would retract 11 papers by Claudio Airoldi, a researcher at the State University of Campinas (UNICAMP) in Brazil. Subsequently, he was suspended for 45 days, and his co-author on the 11 previously pulled papers, Denis de Jesus Lima Guerra, lost his post at the Federal University of Mato Grosso (also in Brazil).

Now, a 12th retraction has appeared for Airoldi — this time in Thermochimica Acta.

Here’s the latest retraction notice, issued earlier this year: Continue reading Researcher in Brazil earns 12th retraction for recycling text and figures

Author loses five papers, most for “compromised” peer review

PLOS OnePLOS ONE has retracted three papers after the first author admitted to submitting the manuscripts without co-authors’ consent, and an investigation suggested that two out of the three papers had received faked reviews.

Last August, the same author — Lishan Wang of the Shanghai Jiao Tong University — lost two more papers (one in Tumor Biology and the other in Gene), also after the peer review process was found to be compromised. All five papers — which share other authors in common — were originally published in 2013, and four list Wang as the first author. The retractions follow an investigation by Shanghai Jiao Tong University.

Here’s the retraction notice for two of the PLOS ONE papers, issued on July 26: Continue reading Author loses five papers, most for “compromised” peer review

Second retraction for bone researcher with lifetime funding ban

via WCH
via WCH

A researcher banned from funding by a Canadian agency for misconduct has earned her second retraction, after a reanalysis uncovered problems with the paper’s conclusions.

The retraction follows an investigation by Sophie Jamal‘s former workplace, the Women’s College Hospital in Toronto, which has led to a recent retraction of a JAMA paper due to data manipulation, and a lifetime funding ban from the Canadian Institutes of Health Research (CIHR).

The latest retraction stemmed from a re-analysis of the paper by the Canadian Multicentre Osteoporosis Study Group, of which the paper was a part; all authors but Jamal have requested the retraction. In the notice, the authors say that they believe no patients were harmed as a result of the “possibly invalid conclusions” in the paper, which showed patients with kidney problems were at higher risk of bone loss. A researcher told us a third paper by Jamal is also due to be retracted soon.

Here’s the retraction notice, issued by the American Journal of Kidney Diseases (AJKD): Continue reading Second retraction for bone researcher with lifetime funding ban

Beleaguered plant scientist with 22 corrections avoids 3 more

CellCell will not be issuing corrections for three papers co-authored by prominent plant biologist Olivier Voinnet, after readers on PubPeer raised questions about some of the images. 

The news may be a welcome relief for Voinnet, based at ETH Zurich in Switzerland, who has recently issued 22 corrections and seven retractions. Ongoing questions about his work have also earned him a three-year funding ban, and caused the European Molecular Biology Organization to revoke an award.

On July 28, Cell published editorial notes for all three papers, which have been collectively cited more than 1000 times (also reported by Leonid Schneider). The notes say that the journal will take “no further action,” noting that the authors of the papers informed Cell of the problems with figures, which do not appear to compromise the papers’ overall validity.  

Here’s the first editorial note, for a 1998 paper: Continue reading Beleaguered plant scientist with 22 corrections avoids 3 more

Cell Press dismisses fraud allegations in high-profile genetics papers

Screen Shot 2016-08-03 at 18.54.35Cell Press has dismissed accusations of image manipulation in two well-cited papers. 

In June 2015, we reported that the publisher was investigating anonymous allegations of more than a dozen instances of manipulation of images in the papers published in Cell and Molecular Cell in 1999 and 2001, respectively. 

After assessing the original high-resolution versions of images from the laboratory notebook of Maria Pia Cosma, the first author of both papers, the journals have not found enough evidence to determine that fraud had occurred. 

Here’s the editorial note, issued last week for both papers (and also reported by Leonid Schneider): Continue reading Cell Press dismisses fraud allegations in high-profile genetics papers

Biologist with five-year funding ban earns 7th and 8th retractions

Biology OpenA biologist in New Jersey has retracted two more papers, bringing his total to eight retractions, following a finding by the U.S. Office of Research Integrity (ORI).

The analysis of the work of John Pastorino, previously a cell biologist at Rowan University, in Glassboro, concluded that he had doctored more than 40 images, resulting in a five-year funding ban.

The report flagged eight published papers (and an unpublished one), six of which had already received expressions of concern (EOCs). Nataly Shulga was a co-author on all eight papers. With these two new retractions in Biology Open and Biochimica et Biophysica Acta (BBA) – Bioenergetics, all of the flagged papers have now been retracted.

Here’s the retraction notice for the Biology Open paper, issued July 15:

Continue reading Biologist with five-year funding ban earns 7th and 8th retractions

Neuroscientist in Serbia earns 8th retraction amid investigation

RadenovicA neurobiologist has notched her eight retraction in the midst of an ongoing investigation into her work by her institution, the University of Belgrade in Serbia.

As we reported previously, a mass clean-up by the Archives of Biological Sciences (ABS), the official journal of the Serbian Biological Society resulted in six retractions of papers co-authored by Lidija Radenović. (Radenović served as vice president of the Serbian Biological Society until July 2014.)

In April, we reported that Radenović was about to notch her seventh retraction in Acta Neurologica Scandinavica; that paper has now been pulled, and ABS has retracted another one of her papers.

Here’s the retraction notice by ABS: Continue reading Neuroscientist in Serbia earns 8th retraction amid investigation

You’ve been dupe’d: Nice data — let’s see them again

As we’ve said before, with hundreds of retractions per year, there are simply too many for us to cover individually.

So from time to time we’ll compile a list of retractions that appeared relatively straightforward, just for record-keeping purposes.

Often, these seemingly straightforward retractions involve duplications, in which authors — accidentally or on purpose — republish their own work elsewhere.

Sometimes journals and authors blame this event on “poor communication,” our first example notes:

Continue reading You’ve been dupe’d: Nice data — let’s see them again

Four more retractions for biomaterials researcher brings total to 7

Journal of Controlled ReleaseA biomaterials researcher has lost four more papers for figure-related issues such as duplications, bringing his total to seven retractions.

We previously reported on three retractions — two by the Journal of Controlled Release (JCR) — of papers co-authored by Hossein Hosseinkhani, who is currently based at the National Taiwan University of Science and Technology in Taipei. Now, the JCR is pulling four more studies that list Hosseinkhani as a co-author.

Here’s the retraction notice for “Enhanced expression of plasmid dna – cationized gelatin complex by ultrasound in murine muscle:” Continue reading Four more retractions for biomaterials researcher brings total to 7

A prominent psychiatry researcher is dismissed. What’s happening to his papers?

neumeister
Alexander Neumeister. Source: Yale School of Medicine

After a prominent researcher was dismissed due to multiple instances of misconduct in his studies, how are journals responding?

When an investigation by the U.S. Food and Drug Administration (FDA) found multiple issues with the work of psychiatry researcher Alexander Neumeister, New York University (NYU) Langone Medical Center shut down eight of his studies. (Disclosure: The author of this post is an NYU journalism student, but has no relationship with the medical school.) The agency concluded the studies, which involved using experimental drugs to relieve symptoms of post-traumatic stress disorder (PTSD), were tainted by lax oversight, falsified records, and inaccurate case histories, according to the New York Times. (Neuroskeptic also recently analyzed the case.)

We reached out to the journals that have published Neumeister’s papers, to ask if these recent events have caused them to take a second look at his work. Several have responded, with some noting they plan to investigate, or will do so if asked by the institution. But many believe there is little cause for concern. Continue reading A prominent psychiatry researcher is dismissed. What’s happening to his papers?